Sera from BC-PIV/S-2PM intranasally vaccinated mice showed efficient inhibitory activities for the interaction between SARS-CoV-2 RBD and hACE2, while those from empty vector-vaccinated mice did not (Figure 6E), suggesting the neutralizing activity of the sera against S protein of SARS-CoV-2. This evidence concerns the gene PROS1 and breast cancer.